@article{paul:hal-04225966,
TITLE = {Quels choix th{\'e}rapeutiques pour {\'e}viter des changements de lignes r{\'e}p{\'e}t{\'e}s chez nos patients ?},
AUTHOR = {Paul, St{\'e}phane and Bouguen, Guillaume},
URL = {https://hal.science/hal-04225966},
JOURNAL = {H{\'e}pato-Gastro \& Oncologie Digestive},
PUBLISHER = {John Libbey Eurotext},
VOLUME = {30},
NUMBER = {S3},
PAGES = {7-17},
YEAR = {2023},
MONTH = Apr, DOI = {10.1684/hpg.2023.2563},
KEYWORDS = {ustekinumab ; vedolizumab ; cytokines ; IBD ; Jak inhibitors ; therapeutic management ; TNF antagonist},
HAL_ID = {hal-04225966},
HAL_VERSION = {v1},
}